Fiasp – some further observations… Or why an artificial pancreas can’t do everything!
I’ve written about the various curveballs that Fiasp has thrown at me on multiple occasions, and for the past few weeks I’ve continued to observe […]
Blog Posts
Defining an “Artificial Pancreas”. Where are we with DIY systems? #WeAreNotWaiting
Back in 2013, in the US, Medtronic launched the 530G pump, and everyone and his dog called it an artificial pancreas. As Scott Hanselmann stated […]
Roll up, roll up. The #Freestyle Libre postcode lottery has started. You gotta be in it to win it….
Earlier today, the first NHS England CCG response to the Libre appeared on Twitter, from the East of England Priorities Advisory Committee. Looking to the […]
Data and user interventions. Multiple challenges for future artificial pancreas systems.
If there’s one thing I’ve learned from my experiences with Fiasp over the past month or so, it’s how important access to my data […]
What goes up…. Must come down. Unless you’re a #PWT1D using #Fiasp.
So then. 10 days after switching back to Novorapid because I was having a devil of a time with the Fiasp, I received a new […]
Abbott’s Freestyle Libre. FDA approved at last. What does this mean?
Two days ago, Abbott announced they had received FDA approval for the Freestyle Libre, some 3 years after European approval. That feels like a long […]
A graphical look at my #Fiasp failure. Does it show anything new?
Whilst I was more or less forced to swap off Fiasp a week or so ago, I thought it might be interesting to take a […]
The latest updates to #OpenAPS try to make life easier once again – available in the dev branch
oref1 has been in the wild in master since the release of 0.5.0 of OpenAPS, introducing the ability to Super-Micro Bolus (SMB) which delivers small […]
After six months with #Fiasp, things have gone awry!
Six months down the line, you’d think that everything was settled and stable. At least, that’s what I’d expect. And then that not so shiny […]
The Abbott Freestyle Libre will be available on the NHS. What does that mean?
If you live in the Social Media bubble for T1D in the UK, you can’t fail to have noticed that there was a press release […]